US HB447 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 27-0)
Status: Introduced on January 10 2019 - 25% progression, died in committee
Action: 2019-01-25 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Affordable and Safe Prescription Drug Importation Act

Sponsors


History

DateChamberAction
2019-01-25HouseReferred to the Subcommittee on Health.
2019-01-10HouseReferred to the House Committee on Energy and Commerce.
2019-01-10HouseIntroduced in House

Same As/Similar To

SB97 (Same As) 2019-01-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB1478 (Related) 2019-03-01 - Referred to the Subcommittee on Health.
SB1801 (Related) 2019-06-12 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback